<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Albrektsen Bredahl | Activity</title>
	<link>https://www.catswannabecats.com/members/deathstore87/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/deathstore87/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Albrektsen Bredahl.</description>
	<lastBuildDate>Mon, 06 Jul 2026 08:03:58 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">624d212edc7bbc618dac598605079f91</guid>
				<title>Albrektsen Bredahl posted an update: t only a prognostic marker but a predictive marker for lung [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/17739/</link>
				<pubDate>Tue, 03 Jun 2025 08:39:13 -0400</pubDate>

									<content:encoded><![CDATA[<p>t only a prognostic marker but a predictive marker for lung adenocarcinoma patients who are good candidates for chemotherapy. Forced CLDN1 expression in low CLDN1-expressing lung adenocarcinoma will increase the chemotherapy response, providing a novel therapeutic strategy.Gastric cancer (GC) is currently the fourth most common malignancy and the&hellip;<span class="activity-read-more" id="activity-read-more-17739"><a href="https://www.catswannabecats.com/activity/p/17739/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">85f2a114a15e7153bcacd6c7788db02e</guid>
				<title>Albrektsen Bredahl posted an update: A high MTV was significantly associated with distant [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/11845/</link>
				<pubDate>Sun, 01 Jun 2025 08:17:27 -0400</pubDate>

									<content:encoded><![CDATA[<p>A high MTV was significantly associated with distant metastases (especially bone metastasis), C-reactive protein (CRP) level, and PD-L1 expression ≥ 75%. Metabolic tumor activity assessed as MTV from 18F-FDG uptake predicted the prognosis after first-line pembrolizumab treatment in patients with NSCLC and PD-L1 expression ≥ 50%, especially&hellip;<span class="activity-read-more" id="activity-read-more-11845"><a href="https://www.catswannabecats.com/activity/p/11845/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d0352ed75225f9aa373effc606f872af</guid>
				<title>Albrektsen Bredahl posted an update: Faltering of growth in early life has been recognized as a [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/5447/</link>
				<pubDate>Sat, 31 May 2025 14:53:10 -0400</pubDate>

									<content:encoded><![CDATA[<p>Faltering of growth in early life has been recognized as a public health challenge among Indian babies. A two-day consultation on growth faltering in early infancy was organized to examine the data and evidence on identification and management of early growth failure and to identify knowledge gaps and future areas of research. The consultation was&hellip;<span class="activity-read-more" id="activity-read-more-5447"><a href="https://www.catswannabecats.com/activity/p/5447/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">be9960e49314bca81176ffd748233658</guid>
				<title>Albrektsen Bredahl became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/5263/</link>
				<pubDate>Sat, 31 May 2025 14:39:59 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>